Reliant Investment Partners LLC Takes $621,000 Position in CVS Health Corporation $CVS

Reliant Investment Partners LLC bought a new position in CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel reports. The fund bought 6,000 shares of the pharmacy operator’s stock, valued at approximately $621,000.

A number of other large investors also recently bought and sold shares of CVS. Caitong International Asset Management Co. Ltd boosted its stake in CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 281 shares in the last quarter. Swiss RE Ltd. bought a new position in shares of CVS Health during the fourth quarter valued at approximately $26,000. Sankala Group LLC purchased a new position in shares of CVS Health during the fourth quarter valued at approximately $28,000. Global Trust Asset Management LLC lifted its holdings in shares of CVS Health by 344.8% during the first quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 300 shares during the last quarter. Finally, Mcguire Capital Advisors Inc. bought a new stake in shares of CVS Health in the 4th quarter worth approximately $28,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Stock Up 0.2%

CVS stock opened at $93.83 on Friday. The business’s 50-day moving average is $102.19 and its two-hundred day moving average is $88.83. CVS Health Corporation has a fifty-two week low of $69.51 and a fifty-two week high of $110.68. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The company has a market cap of $120.01 billion, a price-to-earnings ratio of 24.82, a P/E/G ratio of 0.89 and a beta of 0.61.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The company had revenue of $106.10 billion for the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm’s revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is presently 70.37%.

Wall Street Analyst Weigh In

CVS has been the subject of a number of recent research reports. Wall Street Zen upgraded CVS Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 8th. HSBC restated a “hold” rating and set a $103.00 price target on shares of CVS Health in a report on Monday, July 6th. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. Cantor Fitzgerald increased their price objective on shares of CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, July 7th. Finally, Bank of America upped their target price on shares of CVS Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Twenty-two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.